Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in MGRX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 194K | $70K | +79.5% | 1.919% | 0.00% |
| 2 | Ikarian Capital, LLC | 138K | $50K | 0.0% | 1.363% | 0.01% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 123K | $44K | β | 1.214% | 0.00% |
| 4 | JANE STREET GROUP, LLC | 73K | $26K | +53.1% | 0.718% | 0.00% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 57K | $21K | β | 0.564% | 0.00% |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 38K | $14K | 0.0% | 0.379% | 0.00% |
| 7 | NORTHERN TRUST CORP | 38K | $14K | 0.0% | 0.371% | 0.00% |
| 8 | Ackerman Capital Advisors, LLC | 35K | $12K | 0.0% | 0.340% | 0.00% |
| 9 | INTL FCSTONE INC. | 16K | $6K | β | 0.158% | 0.00% |
| 10 | XTX Topco Ltd | 13K | $5K | β | 0.130% | 0.00% |
| 11 | Sunbelt Securities, Inc. | 12K | $4K | 0.0% | 0.118% | 0.00% |
| 12 | GOLDMAN SACHS GROUP INC | 12K | $4K | β | 0.116% | 0.00% |
| 13 | Csenge Advisory Group | 10K | $4K | 0.0% | 0.099% | 0.00% |
| 14 | ADVISOR GROUP HOLDINGS, INC. | 3K | $1K | +13.9% | 0.032% | 0.00% |
| 15 | Fortitude Family Office, LLC | 1K | $484 | +255.3% | 0.013% | 0.00% |
| 16 | MORGAN STANLEY | 1K | $360 | 0.0% | 0.010% | 0.00% |
| 17 | Tower Research Capital LLC (TRC) | 785 | $283 | -21.7% | 0.008% | 0.00% |
| 18 | Virtu Financial LLC | 61K | $22 | +82.4% | 0.602% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in MGRX β a direct measure of their conviction.
Filings activity in MGRX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 18 | +0.0% | 7.63% | 43.62 pp | $0M | 85% |
| Q4 2025 | 18 | +64% | 51.25% | +28.56 pp | $2M | +126% |
| Q3 2025 | 11 | +10% | 22.69% | +10.52 pp | $1M | +86% |
| Q2 2025 | 10 | +11% | 12.17% | +8.11 pp | $0M | +199% |
| Q1 2025 | 9 | 10% | 4.06% | +0.21 pp | $0M | +5.6% |
| Q4 2024 | 10 | 23% | 3.85% | 4.80 pp | $0M | 56% |
| Q3 2024 | 13 | +63% | 8.65% | +5.23 pp | $0M | +152% |
| Q2 2024 | 8 | β | 3.42% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying MGRX stock.
Based on Q1 2026 13F filings, institutional ownership of Mangoceuticals, Inc. stands at 7.6%, held across 18 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of MGRX, with approximately 194,482 shares worth $0.00B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of MGRX, including JANE STREET GROUP, LLC.
Our composite Smart Money Score for MGRX is 39 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
5 institutions opened new positions in MGRX during Q1 2026, while 5 fully exited. 1 added to existing positions and 12 trimmed.
MGRX institutional ownership fell by 43.62 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 94.7% of all reported 13F value in MGRX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Mangoceuticals, Inc. (MGRX) Institutional Ownership